Company Facts
-
Chairman, President and CEO
- Brian Markison
-
Stock Exchange Listing
- NYSE (KG)
-
Headquarters
- Bristol, TN
-
Commercial Operations
- Bridgewater, NJ
-
Pharmaceutical Manufacturing
- Bristol, TN
- Rochester, MI
- St. Louis, MO
- St. Petersburg, FL
- Middleton, WI
-
Research & Development
- Cary, NC
-
Meridian Auto-Injectors
- Columbia, MD
King Pharmaceuticals Canada
- Mississauga, Ontario, Canada
Alpharma Animal Health
- Bridgewater, NJ
Animal Health Manufacturing
- Chicago Heights, IL
- Longmont, CO
- Salisbury, MD
- Willow Island, WV
- Van Buren, AR
- Shenzhou, China
- Yantai, China
Employees
- 2,600
Sales Force
- 700+
Rankings
Top 9 Best Managed Drug Companies by Fortune – January 2006
Core Competencies
Commercialization and marketing
700 member sales force with strengths in primary care, neuroscience and hospital.
Scientific Operations
Over 100 employees specializing in core R&D, pharmacovigilance, clinical operation, regulatory affairs, medical affairs and project management.
Business development
Manufacturing and quality control:
Ability to produce a broad array of dosage forms including tablets, capsules, liquids, suspensions, solutions, suppositories, creams, ointments, injectables, auto-injector products, and other drug products.
Key Products
- Embeda™ CII
- Avinza® CII
- Flector® Patch
- Skelaxin®
- Thrombin-JMI®
- Levoxyl®
- Cytomel®
- Meridian Auto-Injectors
- EpiPen®
R & D Pipeline
Late Stage
- Remoxy®
- Acurox® Tablets
- Ketoprofen Gel
- CorVue®
- Thrombi-Gel
- Vanquix®
Early to Mid Stage
- T-62
- Oradur Platform
- Aversion® Technology Platform
- Sequestered Naltrexone Platform
